These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30986524)

  • 1. The living croquet theory: The Staphylococcus aureus paradigm.
    Raoult D; Rolain JM
    Int J Antimicrob Agents; 2019 Jun; 53(6):724-725. PubMed ID: 30986524
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of ketolide resistance in Staphylococcus aureus.
    Besier S; Hunfeld KP; Giesser I; Schäfer V; Brade V; Wichelhaus TA
    Int J Antimicrob Agents; 2003 Jul; 22(1):87-8. PubMed ID: 12842336
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial resistance: the example of Staphylococcus aureus.
    Lowy FD
    J Clin Invest; 2003 May; 111(9):1265-73. PubMed ID: 12727914
    [No Abstract]   [Full Text] [Related]  

  • 4. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 5. The path to high drug resistance for staph infections.
    Caspermeyer J
    Mol Biol Evol; 2015 May; 32(5):1372. PubMed ID: 25739737
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial Stewardship Program Implementation of a Quality Improvement Intervention Using Real-Time Feedback and an Electronic Order Set for the Management of Staphylococcus aureus Bacteremia.
    Rosa R; Zavala B; Cain N; Anjan S; Aragon L; Abbo LM
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):346-349. PubMed ID: 29439746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
    Gould IM
    J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monitoring of the resistance to antibiotics of Staphylococcus aureus strains isolated from out-patients].
    Văduva DB; Licker M; Dumitraşcu V; Văduva MB; Velimirovici D; Linţa M; Horhat F; Orb CE; Crăciunescu M; Branea D; Hogea E; Horhat D; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2005; 50(1-2):41-8. PubMed ID: 17300030
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug-Resistant Staphylococcus aureus, India, 2013-2015.
    Kumar M
    Emerg Infect Dis; 2016 Sep; 22(9):1666-7. PubMed ID: 27532265
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug repurposing: a new front in the war against Staphylococcus aureus.
    Das S; Dasgupta A; Chopra S
    Future Microbiol; 2016 Aug; 11():1091-9. PubMed ID: 27494302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of Staphylococcus aureus carriers of mecA gene susceptible to cefoxitine: OS-MRSA].
    Aleixandre-Górriz I; Domínguez-Márquez MV; Martínez-Macías O; Colomina J; Guerrero A
    Rev Esp Quimioter; 2014 Sep; 27(3):215-6. PubMed ID: 25229377
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolates.
    Schmitz FJ; Fluit AC; Lindenlauf E; Scheuring S; Köhrer K
    Eur J Clin Microbiol Infect Dis; 2000 Aug; 19(8):649-50. PubMed ID: 11014635
    [No Abstract]   [Full Text] [Related]  

  • 13. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ; Tice A
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus.
    Renzoni A; Kelley WL; Vaudaux P; Cheung AL; Lew DP
    Trends Microbiol; 2010 Feb; 18(2):55-6. PubMed ID: 20005114
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
    Mariani PG; Sader HS; Jones RN
    J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
    [No Abstract]   [Full Text] [Related]  

  • 16. The killer bug.
    Shnayerson M
    Fortune; 2002 Sep; 146(6):149-50, 152, 154 passim. PubMed ID: 12360834
    [No Abstract]   [Full Text] [Related]  

  • 17. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
    Cameron DR; Howden BP; Peleg AY
    Clin Infect Dis; 2011 Sep; 53(6):576-82. PubMed ID: 21865195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
    Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
    Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.
    Elsaghier AA; Aucken HM; Hamilton-Miller JM; Shaw S; Kibbler CC
    J Antimicrob Chemother; 2002 Feb; 49(2):423-4. PubMed ID: 11815594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.